eimeria acervulina, strain 003 / eimeria brunetti, strain 034 / eimeria maxima, strain 013 / eimeria necatrix, strain 033 / eimeria tenella, strain 004
This is a summary of the European public assessment report (EPAR) for Evalon.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Evalon.
For practical information about using Evalon, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Evalon : EPAR - Summary for the public (PDF/78.52 KB)
First published: 13/05/2016
Last updated: 13/05/2016
|Agency product number||
vaccine against coccidiosis in chickens
|International non-proprietary name (INN) or common name||
|Anatomical therapeutic chemical veterinary (ATCvet) codes||
Laboratorios Hipra, S.A.
|Date of issue of marketing authorisation valid throughout the European Union||
Avda. La Selva 135
12/02/2021 Evalon - EMEA/V/C/004013 - R/0003
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Live parasitic vaccines
Immunologicals for aves
For active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 202011/12/2020